The company said on Friday that it was prepared to accept one of Peltz’s nominees, John Myers, in an attempt to end a proxy war with Trian. Peltz told CNBC on Thursday that DuPont’s offer of one board seat was not enough. Peltz wants two of his fund’s nominees, including himself, on the DuPont Board and two on the board of Chemours, the performance chemicals business DuPont plans to spin off later this year.